Is Adipose Tissue Inflammation the Culprit of Obesity-Associated Comorbidities? por Walter Suárez Carmona | Jul 9, 2025
Gut microbiome in metabolic dysfunction- associated steatotic liver disease and associated hepatocellular carcinoma por Walter Suárez Carmona | Jul 9, 2025
Evaluating the efficacy and safety of survodutide for obesity: a systematic review and meta-analysis of randomized controlled trials por Walter Suárez Carmona | Jun 28, 2025
Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction- associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial por Walter Suárez Carmona | Jun 26, 2025
